Literature DB >> 6600443

Suppressor effect of prostaglandins on T colony formation.

B Klein, J Chaintreuil, A Crastes de Paulet, B Serrou.   

Abstract

This study evaluated the action of prostaglandins on T colony formation. A single step culture process was used which involved direct seeding of freshly isolated peripheral blood mononuclear cells (MC) in semi-solid agar culture medium containing phytohaemagglutinin (PHA). Suppression of endogenous production of prostaglandins with 10(-6) M indomethacin increased T colony formation by up to 100%. Similarly, addition of synthetic prostaglandin E (PGE) to the culture system demonstrated a dose-dependent reduction of T colony formation by PHA-stimulated non-adherent cells. The 50% inhibitory dose (ID 50) was 10(-7) M for PGE2 and 1.3 x 10(-7) M for PGE1. Prostaglandin F had no effect on T colony formation. The synthesis of PGE by adherent cells can be increased two- to three-fold in the presence of T colony promoting activity released by PHA-stimulated lymphocytes. We conclude that monocyte produced PGE is responsible for the suppressor effect exerted by these cells on T colony formation. The PGE inhibitory role is interpreted as a feedback mechanism, modulated by lymphokines released by PHA-activated lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600443      PMCID: PMC1453927     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Clonal proliferation of PHA-stimulated human lymphocytes in soft agar culture.

Authors:  L A Rozenszajn; D Shoham; I Kalechman
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

2.  Induction of colony formation in vitro by human lymphocytes.

Authors:  E Fibach; E Gerassi; L Sachs
Journal:  Nature       Date:  1976-01-15       Impact factor: 49.962

3.  Stimulation and inhibition of human T-lymphocyte colony cell proliferation by hemopoietic cell factors.

Authors:  A Zeevi; I Goldman; L A Rozenszajn
Journal:  Cell Immunol       Date:  1977-02       Impact factor: 4.868

4.  Quantitative comparison of K cell potential in human T and null cells.

Authors:  J Caraux; C Thierry; B Serrou
Journal:  Eur J Immunol       Date:  1978-11       Impact factor: 5.532

5.  A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  In vitro growth of colonies from human peripheral blood lymphocytes stimulated by phytohemagglutinin.

Authors:  N Riou; G Boizard; D Alcalay; P Goube de Laforest; J Tanzer
Journal:  Ann Immunol (Paris)       Date:  1976 Jan-Feb

7.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

8.  Growth characteristics of PHA-induced colonies in primary and secondary agar culture.

Authors:  P Goube de Laforest; N Lasmayous-Riou; D Alcalay; J Tanzer
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

9.  Phorbol myristate acetate: a mitogen selective for a T-lymphocyte subpopulation.

Authors:  J L Touraine; J W Hadden; F Touraine; E M Hadden; R Estensen; R A Good
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

10.  Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.

Authors:  J I Kurland; R Bockman
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  2 in total

1.  Control of human T-colony formation by interleukin-2.

Authors:  M Jourdan; T Commes; B Klein
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

2.  The role of interleukin-2 in T colony formation by human pre-T cells (pTCFC).

Authors:  A Rey; B Klein; C Ilnicki; M Jourdan; B Serrou
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.